Skip to content

Legal status · United Kingdom

Is Semaglutide with B12 legal in the United Kingdom?

Written by Reviewed Sep 2026

Not approvedMetabolicHuman studies cited: 2

Direct answer

No. Semaglutide with B12 is not an approved medicine in the United Kingdom; its classification is "Not licensed". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.

Semaglutide with B12 in the United Kingdom at a glance

ClassificationNot licensed
NoteSemaglutide is licensed; a compounded semaglutide plus B12 mixture is not a licensed medicine.
MHRA approval statusNot approved by MHRA
Human studies cited2 of 4 citations on the profile
ReviewedSep 2026

Classification and note come from the Semaglutide with B12 profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.

What this means

  • 01

    No product containing Semaglutide with B12 is approved by MHRA for any use in the United Kingdom, so nothing on the market is authorized for people.

  • 02

    "Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.

  • 03

    Importing, supplying or promoting it for human use can fall under medicines legislation in the United Kingdom. This page is general information, not legal advice.

What Semaglutide with B12 is

A compounded premix in which the B12 dose is decided by the semaglutide dose rather than by anyone's B12 level. Cyanocobalamin sits at 0.5 mg/mL across strengths while semaglutide is 1 or 5 mg/mL, so the same product delivers five times more B12 per milligram of semaglutide on one strength than on the other. No trial has tested the combination, and no trial supports the reason it is added.

Compounding pharmacies pair semaglutide with cyanocobalamin and the stated reasons are that B12 helps with the nausea and with the fatigue people report on a GLP-1. Neither claim has a trial behind it.

Mechanism: Semaglutide is a GLP-1 receptor agonist that slows gastric emptying and reduces appetite through central and peripheral GLP-1 signalling. Cyanocobalamin is a vitamin B12 form used to correct deficiency, and its physiological effects in a person who is not deficient are minimal.

Regulatory history: Not an approved product. Compounded preparations are not FDA approved and are not reviewed for safety, effectiveness or quality, and FDA has stated concerns about unapproved GLP-1 products sold for weight loss.

How MHRA treats this kind of product

Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.

The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Semaglutide with B12 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Semaglutide with B12 in other countries

Frequently asked questions

Is Semaglutide with B12 legal in the United Kingdom?

No. Semaglutide with B12 is not an approved medicine in the United Kingdom; its classification is "Not licensed". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile. Note: Semaglutide is licensed; a compounded semaglutide plus B12 mixture is not a licensed medicine.

Can I buy Semaglutide with B12 in the United Kingdom?

No approved product exists to buy. In the United Kingdom Semaglutide with B12 is classified as "Not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Semaglutide is licensed; a compounded semaglutide plus B12 mixture is not a licensed medicine.

Is Semaglutide with B12 MHRA approved?

No. In the United Kingdom Semaglutide with B12 is classified as "Not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: Not an approved product. Compounded preparations are not FDA approved and are not reviewed for safety, effectiveness or quality, and FDA has stated concerns about unapproved GLP-1 products sold for weight loss.. On the evidence, 2 human studies are cited on its profile.

Related compounds in the United Kingdom

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Semaglutide with B12 live on its compound profile.

Semaglutide with B12 profile

This page is general information about the regulatory status of Semaglutide with B12 in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.